InvestorsHub Logo

F1ash

10/04/18 12:55 PM

#167648 RE: nidan7500 #167642

DZ for example



Is that a good thing for the MOA?


“In clinical studies, some sigma-1 receptor agonists, including fluvoxamine, donepezil and neurosteroids, improve cognitive impairment and clinical symptoms in neuropsychiatric diseases. “